GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 25/01/2012
PIL Infanrix-IPV

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 06/05/2010 and displayed until 25/01/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
Updated on 29/01/2010 and displayed until 06/05/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 10/12/2008 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 12/04/2007 and displayed until 10/12/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 24/08/2004 and displayed until 12/04/2007
Reasons for adding or updating:
  • New PIL for new product